ClinicalTrials.Veeva

Menu

The Indiana Myeloma Registry

Indiana University logo

Indiana University

Status

Enrolling

Conditions

Plasma Cell Dyscrasias

Treatments

Other: This is a non-interventional trial

Study type

Observational

Funder types

Other

Identifiers

NCT03616483
IUSCC-0661

Details and patient eligibility

About

This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research

Enrollment

2,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female patients ≥ 18 years of age at the time of informed consent

  2. Has been diagnosed with or is suspected to have one of the following:

    1. Monoclonal Gammopathy of Undetermined Significance (MGUS)
    2. Smoldering Multiple Myeloma
    3. Multiple Myeloma
    4. Bony or Soft Tissue Plasmacytoma
    5. Primary Amyloidosis

Exclusion criteria

< 18 years of age

Have not been diagnosed with one of the following:

Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis

Trial contacts and locations

1

Loading...

Central trial contact

Attaya Suvannasankha, MD; Nisha George, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems